Recall of ADVIA CENTAUR SYSTEM - TSH3-ULTRA (TSH3-UL) ASSAY

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    42325
  • Event Risk Class
    III
  • Event Initiated Date
    2013-05-16
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Siemens healthcare diagnostics is informing customers that a rare variant of tsh identified in a small cluster of patients is not detected by the siemens assays. as part of an investigation of unexplained discordant results samples were identified in which the monoclonal antibody used in the reagent failed to detect the tsh molecule. these individuals may have a previously unrecognized functionally normal tsh variant. the observed rate of occurrence during a 30-month time period was 0.6 x 10-7.

Device

  • Model / Serial
    Model Catalog: 06491072 (Lot serial: ALL LOTS); Model Catalog: 06491080 (Lot serial: ALL LOTS)
  • Product Description
    ADVIA CENTAUR SYSTEM - TSH3-ULTRA (TSH3-UL) ASSAY
  • Manufacturer

Manufacturer

  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
  • Source
    HC